Author Archives: Natalie Themm
Life Sciences Day on the Hill 2026 — Recap
Featuring exhibits from over 20 local companies, including medical device, diagnostics, and biotech companies.
Fluidx Embolic IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting
First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
Owlet® Announces Strategic AI Partnership with webAI to Power the Next Generation of Personalized Infant Health and Sleep Insights
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies
Behavioral Health Assessment Using Vocal Biomarkers
Behavioral Health Assessment Using Vocal Biomarkers
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West
Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends
PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease
JP Morgan Healthcare Conference Recap – Photo Gallery
Check out the photo gallery from the 2026 JP Morgan Healthcare conference in San Francisco.
Haemonetics to Acquire Vivasure Medical
The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026
